2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow TOL-463: new trials by email Literature Review of TOL-463 trials Research Report on TOL-463
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suppression Of Bacterial Vaginosis (BV) [SUBVert] Placebo, TOL-463 - Bacterial Vaginosis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 81 | 2019-09-09 | 2023-02-22 |
| TOL-463 Phase 2 Study for Vaginitis TOL-463 - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 2 | Completed | Toltec Pharmaceuticals, LLC | 106 | 2016-07-15 | 2018-03-09 |
Vaginosis, Bacterial (2) · Candidiasis (1) · Candidiasis, Vulvovaginal (1) · Vaginitis (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Toltec Pharmaceuticals, LLC (1)
United States (2)